Skip to main content

Table 1 Demographics of AD-ANCL cases and healthy controls

From: Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss

Individual ID

Age at death

Gender

State

Brain wt. (g)

PMI (h)

Cause of death

1

37

F

Case

1160

4.5

Motor vehicle accident

2

49

F

Case

1010

13.5

Bronchopneumonia

3

50

F

Case

1050

17

Bronchopneumonia

4

50

M

Case

1110

22

Inanition

5

53

F

Case

1005

8

Parry’s disease

6

70

F

Control

1180

16

Carcinoma of colon

7

72

M

Control

980

5

Respiratory failure

8

72

F

Control

1060

16

Inanition

9

73

F

Control

1230

8

Carcinoma of lung

10

81

F

Control

1200

21

Myocardial infarction

11

89

F

Control

1100

33

Respiratory failure

12

90

F

Control

1050

22

Respiratory failure

13

90

M

Control

1320

6.5

Bronchopneumonia

14

91

M

Control

1170

8.5

Myocardial infarction

15

93

F

Control

1155

5

Respiratory failure

  1. Wt weight, PMI post-mortem interval